Reformation
REF
13.08
-0.11
-0.83%
Reformation
US · REF
#3435 by market cap
Listed 2026
13.08
-0.11
-0.83%
Live - 5344 symbols - heartbeat 119s ago
· 2026-10-07 19:54
After-hours
13.01
-0.52%
- Market cap
- 772.76M
- P/E (TTM)i
- 67.08
- P/Bi
- 2.05
- EPSi
- 0.21
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on REF?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.77, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Latest year +15.74% YoY
Margins
- Gross margin
- 60.24%
- Operating margin
- 5.68%
- Net margin
- 2.49%
Key ratios & quality
- Enterprise valuei
- 879.93M
- Altman Z-Scorei
- 1.77
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 359.52M | 438.16M | 507.10M |
| Gross profit | 230.34M | 282.61M | 305.49M |
| Selling & admin expenses | 192.76M | 229.95M | 276.67M |
| Research & development | -- | -- | -- |
| Operating profit | 37.58M | 52.66M | 28.82M |
| Pretax profit | 38.75M | 45.68M | 16.86M |
| Tax | 14.87M | 12.75M | 4.22M |
| Net profit | 23.89M | 32.93M | 12.64M |
| Basic EPS | 0 | 1 | 0 |
| Diluted EPS | 0.40 | 0.56 | 0.21 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 86.09M | 125.07M | 112.30M | 155.23M |
| Gross profit | 51.88M | 80.57M | 79.00M | 103.47M |
| Selling & admin expenses | 55.79M | 67.98M | 91.84M | 84.45M |
| Research & development | -- | -- | -- | -- |
| Operating profit | -3.91M | 12.59M | -12.84M | 19.02M |
| Pretax profit | -7.48M | 9.28M | -16.05M | 17.11M |
| Tax | -1.93M | 2.36M | -3.91M | 4.70M |
| Net profit | -5.55M | 6.92M | -12.15M | 12.41M |
| Basic EPS | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.09 | 0.13 | -0.21 | 0.25 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | -- | 164.31M | 160.91M |
| Cash & ST investments | -- | 87.68M | 65.47M |
| Inventory | -- | 51.92M | 60.64M |
| Total assets | -- | 873.77M | 937.87M |
| Total current liabilities | -- | 81.71M | 106.14M |
| Short-term debt | -- | 16.91M | 24.92M |
| Long-term debt | -- | 155.01M | 147.72M |
| Total liabilities | -- | 447,162,000.00 | 497,070,000.00 |
| Total equity | -- | 426.61M | 440.80M |
| Retained earnings | -- | 69.86M | 82.49M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 161.30M | 210.76M |
| Cash & ST investments | -- | -- | 41.22M | 76.63M |
| Inventory | -- | -- | 70.81M | 81.77M |
| Total assets | -- | -- | 944.69M | 1.01B |
| Total current liabilities | -- | -- | 102.44M | 133.69M |
| Short-term debt | -- | -- | 25.03M | 18.44M |
| Long-term debt | -- | -- | 145.90M | 239.92M |
| Total liabilities | -- | -- | 492,110,000.00 | 628,427,000.00 |
| Total equity | -- | -- | 452.58M | 376.73M |
| Retained earnings | -- | -- | 70.35M | 1.30M |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | 37.81M | 44.27M | 26.67M |
| Depreciation & amortization | 8.48M | 10.10M | 13.17M |
| Free cash flow | 24.12M | 18.12M | -17.87M |
| Dividends paid | -- | -- | -- |
| Stock buybacks / issuance | 0 | -165.48M | 0 |
| Ending cash balance | 76.50M | 87.68M | 65.47M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | -23.53M | 9.32M | -17.20M | 17.22M |
| Depreciation & amortization | 2.86M | 3.02M | 4.16M | 4.25M |
| Free cash flow | -30.68M | -4.59M | -22.02M | 8.83M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- |
| Ending cash balance | 56.19M | 51.16M | 41.22M | 76.63M |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | 7.72 | 2.91 |
| ROA %i | -- | 3.77 | 1.40 |
| ROIC %i | -- | 5.24 | 2.93 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | 10.78 | 12.87 | 6.20 |
| FCF / sales %i | 6.71 | 4.13 | -- |
| Current ratioi | -- | 2.01 | 1.52 |
| Quick ratioi | -- | 1.22 | 0.79 |
| Debt / assetsi | -- | 35.22 | 36.20 |
| LT debt / equityi | -- | 68.18 | 71.36 |
| Interest coveragei | -- | 5.26 | 2.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | 1.33 | 3.06 |
| ROA %i | -- | -- | 0.64 | 1.15 |
| ROIC %i | -- | -- | 1.88 | 2.47 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | 4.12 | 5.20 |
| FCF / sales %i | -- | -- | -- | 0.75 |
| Current ratioi | -- | -- | 1.57 | 1.58 |
| Quick ratioi | -- | -- | 0.71 | 0.79 |
| Debt / assetsi | -- | -- | 36.20 | 43.31 |
| LT debt / equityi | -- | -- | 70.03 | 110.66 |
| Interest coveragei | -- | -- | 1.60 | 2.22 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.